Rain Oncology Inc.
CIK 0001724979
Revenue (TTM)
—
Q3 Nov 2023
Net Income (TTM)
−$67.62M
−47.3% YoY
Q3 Nov 2023
EPS Diluted (TTM)
−$2.04
−2.3% YoY
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
—
Q3 Nov 2023
Net Margin
—
Q3 Nov 2023
Free Cash Flow (TTM)
−$46.31M
Q3 Nov 2023
Cash
$37.31M
Q3 Nov 2023
Total Debt
—
Q3 Nov 2023
Shares Outstanding
36.38M sh
Q3 Nov 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.